Use of specific indicators to detect warfarin-related adverse events.  

The authors describe their work with six hospitals that implemented triggers for warfarin therapy, pharmacist review of the trigger events, and interventions with the providers involved. The authors report a 70% decline in adverse drug events in the course of the 18-month study period.